Efficacy of Intragastric Balloon Placement and Botulinum Toxin Injection in Bariatric Endoscopy
dc.authorwosid | Tatlı, Faik/ABH-7308-2020 | |
dc.contributor.author | Kanlioz, Murat | |
dc.contributor.author | Ekici, Ugur | |
dc.contributor.author | Tatli, Faik | |
dc.contributor.author | Karatas, Turgay | |
dc.date.accessioned | 2024-08-04T20:49:06Z | |
dc.date.available | 2024-08-04T20:49:06Z | |
dc.date.issued | 2020 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Background: To evaluate the results obtained from the combination of intragastric botulinum toxin A (IGBTA), intragastric balloon (IGB), and IGBTA(+)IGB in the treatment of obesity. Materials and Methods: Three separate treatment groups were set up. IGBTA, IGB, and IGBTA(+)IGB were administered to Group 1, 2, and 3, respectively. The body mass indexes (BMI) of patients were measured before and 6 months after the treatment. The intragroup and intergroup treatment results have been evaluated. PResults: The mean BMI decreased by 1.6 kg/m(2) in 40 patients who received IGBTA in group 1 (P<0.001), 3.95 kg/m(2) in 42 patients who received IGB in group 2 (P<0.001), and 4.9 kg/m(2) in 39 patients who received IGBTA and IGB in group 3 (P<0.001) after 6 months of treatment. The intolerance because of the application was the highest in group 3, followed by group 2. Conclusion: The treatment was most successful in group 3 followed by group 2 and group 1, respectively. The authors recommend the group 3 treatment, provided that nausea, vomiting, and flatulence have a high index of probability in such a treatment. However, when deciding between group 1 and group 2 treatments, the authors recommend opting for group 2 treatment that shows to be more efficient. | en_US |
dc.identifier.doi | 10.1097/SLE.0000000000000829 | |
dc.identifier.endpage | 503 | en_US |
dc.identifier.issn | 1530-4515 | |
dc.identifier.issn | 1534-4908 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 32740476 | en_US |
dc.identifier.scopus | 2-s2.0-85097113173 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 500 | en_US |
dc.identifier.uri | https://doi.org/10.1097/SLE.0000000000000829 | |
dc.identifier.uri | https://hdl.handle.net/11616/99654 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000599708300007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Surgical Laparoscopy Endoscopy & Percutaneous Techniques | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | gastric balloon | en_US |
dc.subject | gastric botulinum toxin | en_US |
dc.subject | obesity and obesity treatment | en_US |
dc.subject | bariatric endoscopy | en_US |
dc.subject | body mass index | en_US |
dc.title | Efficacy of Intragastric Balloon Placement and Botulinum Toxin Injection in Bariatric Endoscopy | en_US |
dc.type | Article | en_US |